CRS 2025
- July 14th-18th, 2025
- Philadelphia, Pennsylvania
Schrödinger is excited to be participating in the CRS Annual Meeting 2025 taking place on July 14th – 18th in Philadelphia, Pennsylvania. Join us for a presentation by Schrödinger’s John Shelley and David Nicholson, titled “Molecular modeling and machine learning for drug formulation.” Stop by booth #302 to speak with Schrödinger scientists.
Molecular modeling and machine learning for drug formulation
Speakers:
John Shelley, Fellow, Schrödinger
David Nicholson, Principal Scientist I, MS Applications Scientist, Schrödinger
Abstract:
Schrödinger, a leader in the application of structure-based molecular modeling and machine learning to drug discovery and development, will provide a brief, broad overview on the emerging field of structure-based molecular modeling for drug formulation followed by two more focused presentations: 1. Modeling the formation, structure and behavior of mRNA-containing lipid nanoparticles and 2. Excipient/polymer selection for small-molecule drug formulation including amorphous solid dispersions. We anticipate that attendees will gain an understanding of:
The value and limitations of structure-based molecular modelling and machine learning for drug formulation
Employing modeling to impact excipient selection
How molecular modeling, particularly when combined with experiment, can lead to a competitive advantage by providing insight into complex formulations